SOURCE: CONMED Corporation

CONMED Corporation

February 11, 2014 13:12 ET

CONMED Corporation Comments on Voce Capital Press Release

UTICA, NY--(Marketwired - Feb 11, 2014) - CONMED Corporation (NASDAQ: CNMD) today issued a statement in response to a press release issued by Voce Capital Management LLC, which reportedly owns less than 1% of the outstanding shares of CONMED, announcing its nomination of four director candidates to stand for election to the CONMED Board of Directors at the Company's 2014 Annual Meeting of Stockholders. CONMED shareholders are not required to take any action at this time.

CONMED issued the following statement:

CONMED maintains and welcomes open communications with our shareholders and values their input towards the goal of enhancing shareholder value. We will continue to take actions that we believe enable us to achieve this objective. Currently, we are successfully executing on our business strategy, which the Board believes is in the best interests of all shareholders.

The Company will present its recommendation with respect to the election of directors in its proxy statement to be filed with the Securities and Exchange Commission.

CONMED profile

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Headquartered in Utica, New York, the Company's 3,600 employees distribute its products worldwide from several manufacturing locations. CONMED has a direct selling presence in 16 countries outside the United States and international sales constitute approximately 50% of the Company's total sales.

Forward Looking Information

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to: (i) the failure of any one or more of the assumptions stated above, to prove to be correct; (ii) the risks relating to forward-looking statements discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012; (iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the possibility that any new acquisition or other transaction may require the Company to reconsider its financial assumptions and goals/targets; (vii) increasing costs for raw material, transportation or litigation; (viii) the risk of a lack of allograft tissues due to reduced donations of such tissues or due to tissues not meeting the appropriate high standards for screening and/or processing of such tissues; and/or (ix) the Company's ability to devise and execute strategies to respond to market conditions.

Contact Information

  • CONTACTS:
    CONMED Corporation
    Robert Shallish
    Chief Financial Officer
    315-624-3206


    Joele Frank, Wilkinson Brimmer Katcher
    Andy Brimmer / Jamie Moser
    212-355-4449